Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dosimetry-Driven Quality Measure of Brain Pseudo Computed Tomography Generated From Deep Learning for MRI-Only Radiation Therapy Treatment Planning.
Alvarez Andres E, Fidon L, Vakalopoulou M, Lerousseau M, Carré A, Sun R, Klausner G, Ammari S, Benzazon N, Reuzé S, Estienne T, Niyoteka S, Battistella E, Rouyar A, Noël G, Beaudre A, Dhermain F, Deutsch E, Paragios N, Robert C. Alvarez Andres E, et al. Among authors: sun r. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):813-823. doi: 10.1016/j.ijrobp.2020.05.006. Epub 2020 May 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32417412
Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.
Carré A, Klausner G, Edjlali M, Lerousseau M, Briend-Diop J, Sun R, Ammari S, Reuzé S, Alvarez Andres E, Estienne T, Niyoteka S, Battistella E, Vakalopoulou M, Dhermain F, Paragios N, Deutsch E, Oppenheim C, Pallud J, Robert C. Carré A, et al. Among authors: sun r. Sci Rep. 2020 Jul 23;10(1):12340. doi: 10.1038/s41598-020-69298-z. Sci Rep. 2020. PMID: 32704007 Free PMC article.
Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy.
Sun R, Lerousseau M, Briend-Diop J, Routier E, Roy S, Henry T, Ka K, Jiang R, Temar N, Carré A, Laville A, Hamaoui A, Laurent PA, Rouyar A, Robert C, Robert C, Deutsch E. Sun R, et al. J Immunother Cancer. 2022 Oct;10(10):e004867. doi: 10.1136/jitc-2022-004867. J Immunother Cancer. 2022. PMID: 36307149 Free PMC article.
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C. Sun R, et al. Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14. Lancet Oncol. 2018. PMID: 30120041
7,849 results